NCT04440488: A trial that was reported late by Shire
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT04440488 |
|---|---|
| Title | A Prospective, Randomized, Double-Blind, Parallel Group Study to Evaluate the Safety and Efficacy of ARALAST NP 60 mg/kg and 120 mg/kg for Alpha-1 Proteinase Inhibitor (A1PI) Augmentation Therapy in Subjects With A1PI Deficiency and Chronic Obstructive Pulmonary Disease-Emphysema (COPD-E) |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 8, 2021 |
| Completion date | Sept. 12, 2025 |
| Required reporting date | Sept. 12, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Sept. 15, 2020 |
| Days late | None |